Structural derivatives containing additional hydroxyl groups, such as piceatannol, have demonstrated enhanced inhibitory effects on COX-2 and NF-κB, both key mediators in the pathogenesis of diabetic retinopathy [87,88]. This evidence concerns the gene NFKB1 and diabetic retinopathy.